PubMed

The role of high-dose chemotherapy and stem-cell transplantation in patients with multiple myeloma: a practice guideline of the Cancer Care Ontario Practice Guidelines Initiative.

Imrie K, Esmail R, Meyer RM; Members of the Hematology Disease Site Group of the Cancer Care Ontario Practice Guidelines Initiative.

Ann Intern Med. 2002 Apr 16;136(8):619-29.PMID: 11955031 [PubMed - indexed for MEDLINE]Related articlesFree article

The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.

Kyle RA.

Ann Oncol. 2000;11 Suppl 1:55-8. Review.PMID: 10707780 [PubMed - indexed for MEDLINE]Related articles

Update on the treatment of multiple myeloma.

Kyle RA.

Oncologist. 2001;6(2):119-24. Review.PMID: 11306723 [PubMed - indexed for MEDLINE]Related articlesFree article

Management of patients with multiple myeloma: emphasizing the role of high-dose therapy.

Kyle RA.

Clin Lymphoma. 2001 Jun;2(1):21-8. Review.PMID: 11707866 [PubMed - indexed for MEDLINE]Related articles

High-dose therapy followed by autologous haematopoietic stem cell transplantation in multiple myeloma.

Koh LP, Linn YC, Teoh G, Goh YT, Tan PH.

Ann Acad Med Singapore. 2002 Nov;31(6):731-7.PMID: 12520826 [PubMed - indexed for MEDLINE]Related articles

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.

Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K, Brown J, Drayson MT, Selby PJ; Medical Research Council Adult Leukaemia Working Party.

N Engl J Med. 2003 May 8;348(19):1875-83.PMID: 12736280 [PubMed - indexed for MEDLINE]Related articlesFree article

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: an evidence-based review.

Hahn T, Wingard JR, Anderson KC, Bensinger WI, Berenson JR, Brozeit G, Carver JR, Kyle RA, McCarthy PL Jr.

Biol Blood Marrow Transplant. 2003 Jan;9(1):4-37. Review.PMID: 12533739 [PubMed - indexed for MEDLINE]Related articles

Single versus double autologous stem-cell transplantation for multiple myeloma.

Attal M, Harousseau JL, Facon T, Guilhot F, Doyen C, Fuzibet JG, Monconduit M, Hulin C, Caillot D, Bouabdallah R, Voillat L, Sotto JJ, Grosbois B, Bataille R; InterGroupe Francophone du Myélome.

N Engl J Med. 2003 Dec 25;349(26):2495-502. Erratum in: N Engl J Med. 2004 Jun17;350(25):2628. PMID: 14695409 [PubMed - indexed for MEDLINE]Related articlesFree article

Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma.

Kröger N, Perez-Simon JA, Myint H, Klingemann H, Shimoni A, Nagler A, Martino R, Alegre A, Tomas JF, Schwerdtfeger R, Kiehl M, Fauser A, Sayer HG, Leon A, Beyer J, Zabelina T, Ayuk F, San Miguel JF, Brand R, Zander AR.

Biol Blood Marrow Transplant. 2004 Oct;10(10):698-708.PMID: 15389436 [PubMed - indexed for MEDLINE]Related articles

[Intensive treatment of multiple myeloma]

Harousseau JL.

Bull Acad Natl Med. 2003;187(2):405-13; discussion 413-5. Review. French. PMID: 14556449 [PubMed - indexed for MEDLINE]Related articles

Triple transplantation of autologous peripheral blood stem cells each time following conditioning with 100 mg/m2 of melphalan for multiple myeloma patients in poor performance status.

Rokicka M, Urbanowska E, Torosian T, Dwilewicz-Trojaczek J, Awedan A, Paluszewska M, Wiktor-Jedrzejczak W.

Transplant Proc. 2003 Sep;35(6):2352-4.PMID: 14529939 [PubMed - indexed for MEDLINE]Related articles

European Group for Blood and Marrow Transplantation Registry studies in multiple myeloma.

Björkstrand B.

Semin Hematol. 2001 Jul;38(3):219-25. Review.PMID: 11486309 [PubMed - indexed for MEDLINE]Related articles

Long-term follow up of sequential mobilisation and autologous transplantation with CD34-selected cells in multiple myeloma: a multimodality approach.

Horvath N, Hahn U, Joshua D, Dyson P, Gibson J, Stevens J, Rawling T, Barrow L, Brown R, Stephens S, Gower G, Norman J, Mills B, To LB.

Intern Med J. 2004 Apr;34(4):167-75.PMID: 15086696 [PubMed - indexed for MEDLINE]Related articles

High intensity regimens with autologous hematopoietic stem cell transplantation as treatment of multiple myeloma.

Awedan AA.

Ann Transplant. 2002;7(2):38-43. Review.PMID: 12416471 [PubMed - indexed for MEDLINE]Related articlesFree article

Dose-intensive chemotherapy with growth factor or autologous bone marrow or stem-cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a clinical practice guideline.

Verma S, Younus J, Haynes AE, Stys-Norman D, Blackstein M; the members of the Sarcoma Disease Site Group of Cancer Care Ontario’s Program in Evidence-based Care.

Curr Oncol. 2008 Apr;15(2):80-84.PMID: 18454188 [PubMed - as supplied by publisher]Related articlesFree article

Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.

Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.

Biol Blood Marrow Transplant. 2004 Jun;10(6):395-404.PMID: 15148493 [PubMed - indexed for MEDLINE]Related articles

The role of stem cell transplantation in multiple myeloma.

Harousseau JL, Attal M.

Blood Rev. 2002 Dec;16(4):245-53. Review.PMID: 12350367 [PubMed - indexed for MEDLINE]Related articles

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.PMID: 12042984 [PubMed - indexed for MEDLINE]Related articles

Autologous peripheral blood progenitor cell transplantation for multiple myeloma.

Attal M, Harousseau JL.

Baillieres Best Pract Res Clin Haematol. 1999 Mar-Jun;12(1-2):171-91. Review.PMID: 11000991 [PubMed - indexed for MEDLINE]Related articles

Cytomegalovirus prophylaxis and treatment after hematopoietic stem cell transplantation in Canada: a description of current practices and comparison with Centers for Disease Control/Infectious Diseases Society of America/American Society for Blood and Marrow Transplantation guideline recommendations.

Fraser GA, Walker II; Canadian Blood and Marrow Transplant Group.

Biol Blood Marrow Transplant. 2004 May;10(5):287-97.PMID: 15111928 [PubMed - indexed for MEDLINE]Related articles